AMW GMBH

Organization

Warngau, DE

Organizations

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
APPLICATION APPARATUS FOR AT LEAST ONE IMPLANT
- Publication number 20240342456
- Publication date Oct 17, 2024
- AMW GMBH
- Dirk BARTH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXTRUDED DEPOT FORM FOR CONTROLLED ACTIVE SUBSTANCE RELEASE
- Publication number 20230210763
- Publication date Jul 6, 2023
- AMW GMBH
- Elisabeth RITTER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXTRUDED DEPOT FORM FOR CONTROLLED ACTIVE SUBSTANCE RELEASE
- Publication number 20230210775
- Publication date Jul 6, 2023
- AMW GMBH
- Elisabeth RITTER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREVENTING CRYSTALLIZATION OF ACTIVE INGREDIENTS IN TRANSDERMAL DEL...
- Publication number 20210154154
- Publication date May 27, 2021
- AMW GMBH
- Stefanie RODLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRANSDERMAL DELIVERY SYSTEM CONTAINING A DOPAMINE AGONIST
- Publication number 20210145761
- Publication date May 20, 2021
- AMW GMBH
- Stefanie RODLER
- B65 - CONVEYING PACKING STORING HANDLING THIN OR FILAMENTARY MATERIAL
Information Patent Application
STABILIZED TRANSDERMAL DELIVERY SYSTEM
- Publication number 20200289479
- Publication date Sep 17, 2020
- AMW GMBH
- Verena SONNTAG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXTRUDED DEPOT FORM FOR CONTINUING ACTIVE SUBSTANCE RELEASE
- Publication number 20200093736
- Publication date Mar 26, 2020
- AMW GMBH
- Alexandra PARTENHAUSER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRANSDERMAL THERAPEUTIC SYSTEM WITH CHOLINESTERASE INHIBITOR
- Publication number 20130177606
- Publication date Jul 11, 2013
- AMW GMBH
- Tobias PFALLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Organization

Patents Applicationslast 30 patents

APPLICATION APPARATUS FOR AT LEAST ONE IMPLANT

EXTRUDED DEPOT FORM FOR CONTROLLED ACTIVE SUBSTANCE RELEASE

EXTRUDED DEPOT FORM FOR CONTROLLED ACTIVE SUBSTANCE RELEASE

PREVENTING CRYSTALLIZATION OF ACTIVE INGREDIENTS IN TRANSDERMAL DEL...

TRANSDERMAL DELIVERY SYSTEM CONTAINING A DOPAMINE AGONIST

STABILIZED TRANSDERMAL DELIVERY SYSTEM

EXTRUDED DEPOT FORM FOR CONTINUING ACTIVE SUBSTANCE RELEASE

TRANSDERMAL THERAPEUTIC SYSTEM WITH CHOLINESTERASE INHIBITOR